(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 26.17%4.43B | 12.11%1.89B | 20.23%3.51B | 18.77%1.69B | -5.31%2.92B | -2.24%1.42B | -13.98%3.09B | -11.91%1.45B | 22.26%3.59B | 41.57%1.65B |
Operating income | 26.17%4.43B | 12.11%1.89B | 20.23%3.51B | 18.77%1.69B | -5.31%2.92B | -2.24%1.42B | -13.98%3.09B | -11.91%1.45B | 22.26%3.59B | 41.57%1.65B |
Cost of sales | -23.75%-3.11B | -13.77%-1.33B | -24.43%-2.52B | -19.22%-1.17B | 11.26%-2.02B | 5.17%-982.87M | 1.31%-2.28B | 5.00%-1.04B | -26.70%-2.31B | -54.59%-1.09B |
Operating expenses | -23.75%-3.11B | -13.77%-1.33B | -24.43%-2.52B | -19.22%-1.17B | 11.26%-2.02B | 5.17%-982.87M | 1.31%-2.28B | 5.00%-1.04B | -26.70%-2.31B | -54.59%-1.09B |
Gross profit | 32.26%1.32B | 8.35%559.34M | 10.81%999.81M | 17.75%516.25M | 11.41%902.26M | 5.02%438.43M | -36.80%809.82M | -25.40%417.48M | 15.00%1.28B | 21.61%559.64M |
Selling expenses | -13.03%-195.91M | -17.18%-85.41M | -23.21%-173.32M | -2.61%-72.89M | 19.84%-140.67M | 26.36%-71.03M | 9.21%-175.49M | -19.33%-96.46M | -12.94%-193.3M | -33.89%-80.84M |
Administrative expenses | -11.20%-293.54M | -10.11%-122.15M | -15.42%-263.98M | -21.71%-110.94M | -14.95%-228.71M | -4.18%-91.15M | 7.63%-198.96M | -23.30%-87.5M | -9.21%-215.4M | -9.41%-70.96M |
Research and development expenses | -39.10%-111.67M | -17.82%-43.28M | -13.44%-80.28M | -84.98%-36.73M | -25.63%-70.77M | -5.10%-19.86M | -8.99%-56.33M | -35.80%-18.89M | -84.57%-51.68M | -75.47%-13.91M |
Impairment and provision | -306.48%-89.82M | -114.34%-35.5M | 194.79%43.5M | 59.17%-16.56M | 45.00%-45.89M | -6.22%-40.57M | 4.85%-83.44M | -44.92%-38.19M | -16.61%-87.69M | -19.59%-26.36M |
-Other impairment is provision | -306.48%-89.82M | -114.34%-35.5M | 194.79%43.5M | 59.17%-16.56M | 45.00%-45.89M | -6.22%-40.57M | 4.85%-83.44M | -44.92%-38.19M | -16.61%-87.69M | -19.59%-26.36M |
Special items of operating profit | -111.29%-17.29M | -53.13%10.08M | 514.45%153.11M | 64.14%21.51M | -38.13%24.92M | 63.74%13.1M | 22,785.80%40.28M | 50.12%8M | -98.52%176K | -28.42%5.33M |
Operating profit | -9.69%600.69M | -5.71%277.86M | 54.87%665.15M | 32.51%294.7M | 32.34%429.48M | 25.08%222.39M | -54.90%324.53M | -51.45%177.81M | 11.69%719.58M | 19.11%366.26M |
Financing income | 49.52%26.85M | -14.30%11.06M | 189.40%17.96M | 107.44%12.9M | -66.92%6.21M | -13.81%6.22M | 457.17%18.76M | 1,482.68%7.22M | 31.27%3.37M | -76.36%456K |
Financing cost | 17.56%-221.98M | 30.80%-99.61M | -4.21%-269.25M | -24.68%-143.95M | 17.37%-258.38M | 47.16%-115.45M | -4.75%-312.69M | -41.52%-218.5M | 0.51%-298.5M | 1.85%-154.39M |
Share of profits of associates | -71.24%2M | 3,494.62%3.34M | 38,516.67%6.95M | --93K | --18K | ---- | ---- | ---- | ---- | ---- |
Share of profit from joint venture company | 155.70%171K | 112.29%74K | 75.30%-307K | -34.68%-602K | -981.56%-1.24M | -469.42%-447K | -81.50%141K | -66.01%121K | 114.65%762K | 423.64%356K |
Earning before tax | -3.04%407.73M | 18.13%192.72M | 138.81%420.5M | 44.74%163.15M | 472.84%176.08M | 437.93%112.72M | -92.77%30.74M | -115.68%-33.36M | 22.48%425.21M | 39.91%212.68M |
Tax | -52.28%-187.17M | -19.76%-89.37M | -22.02%-122.91M | -7.64%-74.62M | 12.02%-100.73M | -27.26%-69.32M | 19.81%-114.5M | 19.18%-54.47M | -48.06%-142.79M | -74.33%-67.4M |
After-tax profit from continuing operations | -25.88%220.56M | 16.75%103.35M | 294.94%297.59M | 104.01%88.53M | 189.96%75.35M | 149.41%43.39M | -129.66%-83.76M | -160.45%-87.83M | 12.64%282.42M | 28.17%145.28M |
Earning after tax | -25.88%220.56M | 16.75%103.35M | 294.94%297.59M | 104.01%88.53M | 189.96%75.35M | 149.41%43.39M | -129.66%-83.76M | -160.45%-87.83M | 12.64%282.42M | 28.17%145.28M |
Minority profit | 536.00%24.05M | 352.35%5.48M | 20.72%3.78M | -479.72%-2.17M | -74.08%3.13M | -82.22%572K | -12.67%12.08M | 4,279.22%3.22M | -51.10%13.84M | -100.27%-77K |
Profit attributable to shareholders | -33.12%196.51M | 7.91%97.87M | 306.84%293.81M | 111.80%90.7M | 175.35%72.22M | 147.03%42.82M | -135.69%-95.84M | -162.64%-91.05M | 20.75%268.58M | 71.10%145.36M |
Basic earnings per share | -33.37%0.0675 | 6.39%0.0333 | 306.83%0.1013 | 114.38%0.0313 | 177.33%0.0249 | 148.18%0.0146 | -136.02%-0.0322 | -162.60%-0.0303 | 12.88%0.0894 | 51.72%0.0484 |
Diluted earnings per share | -32.73%0.0666 | 6.11%0.033 | 302.44%0.099 | 115.97%0.0311 | 176.40%0.0246 | 147.52%0.0144 | -136.22%-0.0322 | -163.13%-0.0303 | 13.54%0.0889 | 52.38%0.048 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data